NO20003051L - Metode for administrering av AspB28-humant insulin - Google Patents

Metode for administrering av AspB28-humant insulin

Info

Publication number
NO20003051L
NO20003051L NO20003051A NO20003051A NO20003051L NO 20003051 L NO20003051 L NO 20003051L NO 20003051 A NO20003051 A NO 20003051A NO 20003051 A NO20003051 A NO 20003051A NO 20003051 L NO20003051 L NO 20003051L
Authority
NO
Norway
Prior art keywords
administration
human insulin
aspb28 human
insulin
asphuman
Prior art date
Application number
NO20003051A
Other languages
English (en)
Norwegian (no)
Other versions
NO20003051D0 (no
Inventor
Richard Dennis Dimarchi
Roger Garrick Harrison
Ronald Keith Wolff
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20003051L publication Critical patent/NO20003051L/no
Publication of NO20003051D0 publication Critical patent/NO20003051D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
NO20003051A 1998-01-08 2000-06-14 Metode for administrering av AspB28-humant insulin NO20003051D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7075298P 1998-01-08 1998-01-08
PCT/US1999/000290 WO1999034815A1 (en) 1998-01-08 1999-01-07 Method for administering aspb28-human insulin

Publications (2)

Publication Number Publication Date
NO20003051L true NO20003051L (no) 2000-06-14
NO20003051D0 NO20003051D0 (no) 2000-06-14

Family

ID=22097181

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20003051A NO20003051D0 (no) 1998-01-08 2000-06-14 Metode for administrering av AspB28-humant insulin
NO20003050A NO20003050L (no) 1998-01-08 2000-06-14 Metode for Õ administrere monomere insulinanaloger

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20003050A NO20003050L (no) 1998-01-08 2000-06-14 Metode for Õ administrere monomere insulinanaloger

Country Status (16)

Country Link
US (2) US20010053761A1 (ko)
EP (2) EP0951911A3 (ko)
JP (2) JP2002500193A (ko)
KR (2) KR20010033940A (ko)
CN (2) CN1287492A (ko)
AU (2) AU754707B2 (ko)
BR (2) BR9906813A (ko)
CA (2) CA2317739A1 (ko)
EA (2) EA200000747A1 (ko)
HU (2) HUP0101293A3 (ko)
IL (2) IL137150A0 (ko)
NO (2) NO20003051D0 (ko)
PL (2) PL342745A1 (ko)
TR (2) TR200001891T2 (ko)
WO (2) WO1999034815A1 (ko)
ZA (2) ZA99104B (ko)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6131567A (en) * 1993-01-29 2000-10-17 Aradigm Corporation Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
US20060171899A1 (en) * 1998-12-10 2006-08-03 Akwete Adjei Water-stabilized aerosol formulation system and method of making
US6858199B1 (en) * 2000-06-09 2005-02-22 Advanced Inhalation Research, Inc. High efficient delivery of a large therapeutic mass aerosol
WO2001000674A1 (en) * 1999-06-29 2001-01-04 Eli Lilly And Company Insulin crystals for pulmonary administration
US6458387B1 (en) * 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
ATE430558T1 (de) 2000-10-27 2009-05-15 Baxter Healthcare Sa Herstellung von mikrokügelchen
DE60226613D1 (de) * 2001-08-16 2008-06-26 Baxter Int Darreichungsformen welche mikropartikel und treibgas enthalten
EP1944016A1 (en) 2001-08-16 2008-07-16 Baxter International Inc. Propellant-based microparticle formulatons
WO2003047553A1 (en) * 2001-12-07 2003-06-12 Eiffel Technologies Limited Synthesis of small particles
AU2002359730A1 (en) * 2001-12-21 2003-07-30 Smithkline Beecham Corporation Compositions and methods for altering glucose production
US6985798B2 (en) * 2002-05-10 2006-01-10 Oriel Therapeutics, Inc. Dry powder dose filling systems and related methods
US7677411B2 (en) * 2002-05-10 2010-03-16 Oriel Therapeutics, Inc. Apparatus, systems and related methods for processing, dispensing and/or evaluatingl dry powders
SI1535349T1 (sl) * 2002-06-27 2014-10-30 Oriel Therapeutics, Inc. Naprave, sistemi in ustrezni postopki za predelavo, izdajo in/ali vrednotenje nefarmacevtskih suhih praškov
US20070277820A1 (en) * 2003-10-27 2007-12-06 Timothy Crowder Blister packages and associated methods of fabricating dry powder drug containment systems
US7377277B2 (en) * 2003-10-27 2008-05-27 Oriel Therapeutics, Inc. Blister packages with frames and associated methods of fabricating dry powder drug containment systems
US7451761B2 (en) * 2003-10-27 2008-11-18 Oriel Therapeutics, Inc. Dry powder inhalers, related blister package indexing and opening mechanisms, and associated methods of dispensing dry powder substances
WO2005065756A2 (en) 2003-12-30 2005-07-21 Oriel Therapeutics, Inc. Dry powder nebulizers and associated methods of dispensing dry powders
US7624733B2 (en) 2004-02-09 2009-12-01 Oriel Therapeutics, Inc. Inhalers with extendable/retractable forward member and associated methods of dispensing inhalant substances
CA2616997C (en) 2004-09-13 2014-12-23 Oriel Therapeutics, Inc. Dry powder inhalers that inhibit agglomeration, related devices and methods
CN101313293B (zh) * 2005-08-25 2011-06-15 奥里尔治疗公司 具有棒、相关的包、干粉吸入器的药物贮库系统和方法
WO2007089477A2 (en) 2006-01-31 2007-08-09 Oriel Therapeutics, Inc. Dry powder inhalers having spiral travel paths, unit dose microcartridges with dry powder, related devices and methods
EP2060268A1 (en) * 2007-11-15 2009-05-20 Novo Nordisk A/S Pharmaceutical compositions for pulmonary or nasal delivery of peptides
CA2732842C (en) 2008-09-26 2018-01-09 Oriel Therapeutics, Inc. Inhalers with airway disks having discrete airway channels and related disks and methods
US8887722B2 (en) * 2008-09-26 2014-11-18 Oriel Therapeutics, Inc. Inhaler mechanisms with radially biased piercers and related methods
CN102159269B (zh) 2008-09-26 2014-05-07 奥里尔治疗公司 一种带有双穿刺元件的干燥粉末吸入器以及相关装置和方法
WO2010039201A2 (en) * 2008-09-30 2010-04-08 Oriel Therapeutics, Inc. Dry powder inhalers with multi-facet surface deagglomeration chambers and related devices and methods
US8991391B2 (en) * 2008-09-30 2015-03-31 Oriel Therapeutics, Inc. Dry powder inhalers with endless strips and cooperating piercers and related methods
WO2010039202A2 (en) * 2008-10-01 2010-04-08 Oriel Therapeutics, Inc. Dry powder inhalers with rotating piercing mechanisms and related devices and methods
JP5341532B2 (ja) * 2009-01-19 2013-11-13 第一電子工業株式会社 １対の誤嵌合防止キー及び該キーを用いた電気コネクタ
CN101912600B (zh) * 2010-01-11 2014-01-29 杨国汉 改善胰岛素在溶液中稳定性的方法
WO2011080747A2 (en) 2010-01-27 2011-07-07 Aespira Ltd. Dry powder inhaler
USD641076S1 (en) 2010-03-26 2011-07-05 Oriel Therapeutics, Inc. Dry powder inhaler
USD635246S1 (en) 2010-03-26 2011-03-29 Oriel Therapeutics, Inc. Dose disk for dry powder inhalers
US10238820B2 (en) 2014-01-08 2019-03-26 Seroton, Inc. Dry-powder inhalation device
US11491288B2 (en) 2014-01-08 2022-11-08 Seroton, Inc. Dispenser for dry-powder inhalation devices
WO2024100652A1 (en) 2022-11-07 2024-05-16 Kritzman Kadron Amnon High performance dry powder inhaler

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK179286D0 (da) * 1986-04-18 1986-04-18 Nordisk Gentofte Insulinpraeparat
PT93057B (pt) * 1989-02-09 1995-12-29 Lilly Co Eli Processo para a preparacao de analogos da insulina
US5230884A (en) * 1990-09-11 1993-07-27 University Of Wales College Of Cardiff Aerosol formulations including proteins and peptides solubilized in reverse micelles and process for making the aerosol formulations
US6131567A (en) * 1993-01-29 2000-10-17 Aradigm Corporation Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
DE10199011I2 (de) * 1993-06-21 2004-10-14 Novo Nordisk As ASP-B28-Insulinkristalle.
DK72793D0 (da) * 1993-06-21 1993-06-21 Novo Nordisk As Nyt produkt
TW402506B (en) * 1993-06-24 2000-08-21 Astra Ab Therapeutic preparation for inhalation
US5451569A (en) * 1994-04-19 1995-09-19 Hong Kong University Of Science And Technology R & D Corporation Limited Pulmonary drug delivery system
US5461031A (en) * 1994-06-16 1995-10-24 Eli Lilly And Company Monomeric insulin analog formulations
US5547929A (en) * 1994-09-12 1996-08-20 Eli Lilly And Company Insulin analog formulations
YU18596A (sh) * 1995-03-31 1998-07-10 Eli Lilly And Company Analogne formulacije monomernog insulina
CA2223272A1 (en) * 1995-05-05 1996-11-07 Ronald Eugene Chance Single chain insulin with high bioactivity

Also Published As

Publication number Publication date
NO20003050D0 (no) 2000-06-14
CN1195543C (zh) 2005-04-06
HUP0100391A3 (en) 2001-12-28
EA200000747A1 (ru) 2000-12-25
EP0951910A3 (en) 2002-06-19
AU2107399A (en) 1999-07-26
US20010053761A1 (en) 2001-12-20
US20010007853A1 (en) 2001-07-12
CA2317739A1 (en) 1999-07-15
CA2317733A1 (en) 1999-07-15
PL341592A1 (en) 2001-04-23
PL342745A1 (en) 2001-07-02
KR20010033940A (ko) 2001-04-25
AU747619B2 (en) 2002-05-16
TR200001892T2 (tr) 2000-11-21
JP2002500193A (ja) 2002-01-08
EA200000748A1 (ru) 2000-12-25
NO20003050L (no) 2000-06-14
TR200001891T2 (tr) 2000-11-21
BR9906796A (pt) 2000-11-14
KR20010033941A (ko) 2001-04-25
WO1999034816A1 (en) 1999-07-15
IL137105A0 (en) 2001-06-14
EP0951910A2 (en) 1999-10-27
JP2002500192A (ja) 2002-01-08
BR9906813A (pt) 2001-03-20
IL137150A0 (en) 2001-07-24
HUP0101293A2 (hu) 2001-08-28
AU2312299A (en) 1999-07-26
AU754707B2 (en) 2002-11-21
CN1287491A (zh) 2001-03-14
EP0951911A3 (en) 2002-06-19
ZA99104B (en) 2000-07-07
HUP0100391A2 (hu) 2001-08-28
HUP0101293A3 (en) 2001-12-28
WO1999034815A1 (en) 1999-07-15
CN1287492A (zh) 2001-03-14
NO20003051D0 (no) 2000-06-14
EP0951911A2 (en) 1999-10-27
ZA99105B (en) 2000-07-07

Similar Documents

Publication Publication Date Title
NO20003051L (no) Metode for administrering av AspB28-humant insulin
WO2002065985A3 (en) Methods of treating diabetes mellitus
EA200100289A1 (ru) Способ введения инсулинотропных пептидов
MXPA05007470A (es) Metodo para reducir la morbilidad y mortalidad cardiovascular en pacientes prediabeticos y pacientes con diabetes de tipo 2.
IL208184A0 (en) Glp-1, and methods for treating diabetes
MY145590A (en) Phenylacetamides and their use as glucokinase modulators
WO2000016797A3 (en) Use of glp-1 or analogs in treatment of stroke
DK1373215T3 (da) Gelanamycinderivater egnet til behandling af cancer
MXPA03006855A (es) Metodo para tratar insuficiencia cardiaca cronica y/o niveles elevados de colesterol, utilizando acido 3,5-diyodotiropropionico, y metodo para su preparacion.
MXPA05008649A (es) Terapia de combinacion para el tratamiento de desordenes inmunoinflamatorios.
WO2004043341A3 (en) Treatment for hemorrhagic shock
WO2004050115A3 (en) Combination treatment using exendin-4 and thiazolidinediones
ATE239474T1 (de) Verwendung von levobupivacain
DE60222383D1 (de) Medikament zur verabreichung von amifostin und verwandten wirkstoffen
AU3308099A (en) Method for the treatment of pain, including chronic and female specific pain
ATE409042T1 (de) Verwendung von sulodexide zur behandlung von diabetischer nephropathie
IL151878A0 (en) Pharmaceutical compositions containing t3
SE9101341D0 (sv) New medicinal use
AU6102801A (en) Method of preventing or treating diabetes
DE60120371D1 (de) Verwendung von wachstumshormon in niederen dosen
MD1469G2 (ro) Metodă de tratament al şocului combustional
UA22223A (uk) Спосіб лікуваhhя захворюваhь оргаhа зору
UA38996A (uk) Спосіб лікування хронічного панкреатиту із супутньою ішемічною хворобою серця у людей похилого та старечого віку
UA29106A (uk) Спосіб лікування вібраційної хвороби
UA34199A (uk) Спосіб лікування пародонтиту

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application